Increased expression of mac25/insulin-like growth factor binding-protein related protein-1 (IGFBP-rP1) in human breast and prostate epithelial cell lines results in the suppression of tumor growth. CDNA expression array analysis revealed increased manganese superoxide dismutase (SOD-2) expression in the mac25/IGFBP-rP1-transfected M12 human prostate cancer cell line compared to M12 control cells. SOD-2 has been postulated to be a tumor suppressor. SOD-2 was also increased in LNCaP cells stably transfected with mac25/IGFBP-rP1, but not in mac25/IGFBP-rP1-transfected PC-3 cells. Mac25 LNCaP cells had a marked decrease in tumor growth in nude mice compared to controls, but there was no difference in tumor growth in mac25 PC-3 cells compared to control. Phosphorylated Erk and Akt were increased in the M12 and LNCaP transfected mac25/ IGFBP-rP1 cells but not PC-3 mac25. Inhibition of PI-3 kinase results in a marked decrease in viability of the M12-mac25 cells compared to M12 controls. Cells treated with H 2 O 2 result in an increase in phospho-ERK. Transfection of SOD-2 in M12 cells markedly decreased tumor growth, apoptosis, G1 delay in the cell cycle, and expression of senescence associated b-galactosidase. These results suggest that one of the downstream mediators of the senescence-associated tumor suppression effect of mac25/IGFBP-rP1 is SOD-2.
Introduction
Mac 25, also termed insulin-like growth factor bindingprotein-related protein-1 (IGFBP-rP1), is a senescenceassociated gene that demonstrates decreased expression in prostate cancer (Hwa et al., 1998a) . Re-expression of mac25/IGFBP-rP1 in malignant human prostate epithelial cells with the potential to undergo senescence results in a marked decrease in tumor growth compared to control cells in nude mice tumor injection studies (Sprenger et al., 1999) . The mechanism by which mac25/IGFBP-rP1 suppresses tumor growth has recently been shown to involve the inhibition of cell-cycle progression at G1 and enhanced apoptosis. The increased apoptosis is associated with the unscheduled expression of cyclin A (Sprenger et al., 2002) . In addition to decreased tumor growth, re-expression of mac25/IGFBP-rP1 results in the expression of senescence-associated b-galactosidase that is consistent with the expression of mac25/IGFBP-rP1 in senescent prostate epithelial cells (Lopez-Bermejo et al., 2000) . Thus, mac25/IGFBP-rP1's function as a tumor suppressor gene occurs, in part, through induction of cell senescence.
Recent data demonstrate that mac25/IGFBP-rP1 is targeted to the nucleus and is a potential transcription factor (Wilson et al., 2001) . This suggests the possibility that mac25/IGFBP-rP1 may have its phenotypic activity induced through the activity of downstream genes. In this study, we used cDNA expression arrays to search for genes induced by mac25/IGFBP-rP1 that are involved in the senescence process. Among the genes that were induced, superoxide dismutase-2 (SOD-2, manganese superoxide dismutase) was of interest because deHaan et al. (1996) have shown that SOD-1 (Cu/ZnSOD) has the potential to induce apoptosis through the generation of hydrogen peroxide (H 2 O 2 ). Since administration of H 2 O 2 directly to cells will induce senescence, as defined by an increase in senescence-associated b-galactosidase expression and a change in cell morphology, SOD-2 should also potentially be able to induce senescence via H 2 O 2 production . SOD-2 expression is decreased in the progression from benign to malignant prostate epithelium, and when re-expressed in human prostate cancer cell lines causes tumor regression (Baker et al., 1997; Li et al., 1998b; Bostwick et al., 2000) . At least one mechanism by which SOD-2 decreases tumor growth is by causing a delay at G0/G1 in the cell cycle (Li et al., 1998b; Oberley, 2001) . In addition to the action of SOD-2 in prostate cancer, the antioxidant properties of SOD-2 make it an enzyme of general interest in cancer prevention and tumor suppression (Oberley and Oberley, 1997; Oberley, 2001; Zhong and Oberley, 2001) .
Results

Cell lines
In addition to the M12 cell lines expressing mac25/ IGFBP-rP1 that have been reported previously, in this study the transfection of mac25/IGFBP-rP1 into LNCaP and PC-3 cells resulted in clones that expressed mac25/IGFBP-rP1 levels between 5-10-fold above those of the wild-type parental cells (Figure 1 ) (Sprenger et al., 1999) .
Alterations in gene expression mediated by mac25/ IGFBP-rP1
cDNA microarray analysis of M12 cells was performed to identify transcriptional alterations resulting from the expression of mac25/IGFBP-rP1. Of approximately 6000 genes assayed, 12 exhibited reproducible transcriptional alterations of two-fold or greater (Table 1) . Of these, the expression of SOD-2 increased 3.33-fold in cells transfected with mac25/IGFBP-rP1 relative to controls. SOD-2 is involved in the generation of H 2 O 2 from superoxide in mitochondria. SOD-2 also causes cells to develop a senescent phenotype and causes growth inhibition of tumor cells in vivo and in vitro. Therefore, SOD-2 was selected as a potential mediator of some of the functions of mac25/IGFBP-rP1 in prostate epithelial cells.
The differences in expression of SOD-2 between the M12 control cells and the mac25/IGFBP-rP1 M12 cells were confirmed by Northern and Western analyses, (Figure 1 ). Enzymatic SOD activity was significantly increased in M12-mac25/IGFBP-rP1 and M12-SOD-2 sense compared to M12 control cells (Figure 2 ), whereas SOD-2 mRNA and immunoreactive protein and total SOD enzymatic activity was decreased in M12 antisense (AS) cells compared to M12 control cells (Figure 1b) . Specific SOD-2 assays confirmed that the differences in SOD activity between cell constructs were because of SOD-2 (data not shown).
Mac25/IGFBP-rP1 expression in PC-3 and LNCaP cells
In order to determine if SOD-2 was induced in response to increased mac25/IGFBP-rP1 expression in other human prostate epithelial cancer cell lines, we constructed clones of LNCaP and PC-3 cells expressing mac 25/IGFBP-rP1 (Figure 1a ). Similar to our previous observation with M12 cells, the LNCaP cells had an increase in senescence as determined by the detection of SA-b galactosidase. In contrast, there was no difference in SA-b galactosidase expression between parental PC-3 cells and those expressing mac25/IGFBP-rP1. SOD-2 expression was increased in the mac25/IGFBP-rP1- Figure 1 Northern and Western blots and total SOD bioassay demonstrating an increase in SOD-2 expression associated with transfection of mac25/IGFBP-rP1 into M12 and LnCaP, but not PC-3, cells. (a) Northern and Western analyses of cytoplasmic RNA and cell lysate, respectively, from representative clones of M12-, LNCaP-, and PC-3-control cells compared to the same cell lines transfected with mac25/IGFBP-rP1 (M12-mac25, LNCaPmac25, and PC-3-mac25). Northern analyses were probed with mac25/IGFBP-rP1 cDNA and Western analyses with an antimac25/IGFBP-rP1 and anti SOD-2. Note the marked increase in mac 25 and SOD-2 expression in each of the transfected cell lines except for PC-3 mac25/IGFBP-rP1 that showed a marked decrease in SOD-2. Cells were grown in complete RPMI medium described in Materials and methods without FCS. Actin was used as a loading control for Western analyses and Northern analysis RNA was evenly loaded as determined by ethidium bromide stained 28S ribosomal RNA (data not shown). (b) Mean levels SOD enzymatic activity in M12-control, M12-mac25, M12-SOD-2 sense, and M12-SOD-2 antisense cells. * ¼ Pp0.01 compared to M12 control cells expressing LNCaP clones, but SOD-2 was decreased in the PC-3 cells (Figure 1 ). Finally, there was no difference in tumor volume in the mac25/IGFBP-rP1-expressing PC-3 cells, compared to parental cells, whereas the mac25/IGFBP-rP1-transfected LNCaP cells demonstrated a marked decrease in tumor volume compared to LNCaP control cells, similar to the effects previously reported in M12 cells, Figure 2 (Sprenger et al., 1999 (Sprenger et al., , 2002 .
SOD-2 expression in M12 cells
In order to determine if the expression of SOD-2 could account for some of the phenotypic findings noted from expression of mac25/IGFBP-rP1 in M12 and LnCaP, we selected clones of M12 cells transfected with pcDNA3 containing SOD-2 ligated in either a sense or antisense direction. As noted in Figure 3 , SOD-2 was markedly overexpressed in the sense clones, whereas SOD-2 expression was decreased in the antisense clones. SOD enzymatic activity was also significantly different between clones made with either sense or antisense constructs as noted in Figure 1b . This assay measures total SOD enzymatic activity and it is possible that other SOD forms also changed with transfection of SOD-2; however, no changes in CuZnSOD expression was noted on Western analysis (data not shown) and catalase expression was not altered Figure 3 . SOD enzymatic activity was significantly increased in M12-mac25 expressing cells and M12-SOD 2 sense cells compared to M12 control cells; whereas enzymatic activity was significantly decreased in the SOD-2 antisense cells compared to controls (Figure 1b) . In addition to total SOD activity, specific SOD-1 and SOD-2 activities were measured in the M12 cells expressing mac25/IGFBP-rP1 and M12 control cells. SOD-1 levels were 26.7 and 20.6 U and SOD-2 levels were 40 and 6.7 in M12 cells expressing mac25/IGFBP-rP1 and M12 control cells, respectively.
Growth rate and apoptosis in M12 SOD cells
Growth rates of two M12 SOD-2 sense clones and two M12 SOD-2 antisense clones were determined by cell counts from triplicate wells at 24 h intervals from 24 to 96 h after plating. As shown in Figure 4a , the growth rates for the SOD-2 cells were significantly slower (Pp0.01) than those obtained from the M12 control and SOD-2 antisense cell lines. Since our previous studies had indicated that the expression of mac 25/ IGFBP-rP1 resulted in both inhibition of the cell cycle and an increase in apoptosis, we also examined apoptosis in parallel cultures from the same clones used for proliferation studies. As shown in Figures 4b and c , there was a significant difference in apoptosis between the cell lines based on cleavage of caspases 3 and 7. Although cells can potentially recover following caspase 3 cleavage, this cleavage occurs during a later stage in the apoptotic pathway and since cell viability and cell number are decreased, it is very likely that the decrease in viable cell numbers is due, at least in part, to apoptosis. The SOD-2 sense cells also demonstrated an increase in cleaved PARP, further indicating activation of an apoptotic pathway (data not shown). Apoptosis assays were performed at 21% O 2 concentration.
Tumor Growth in Nude Mice of Cells Overexpressing SOD-2
There was a marked decrease in tumor volume in the M12 SOD-2 sense clones compared to M12 
Flow cytometry using propidium iodide
The results of the flow cytometry data demonstrated that 4074 (s.e.m) % of the M12 control DNA resided in G0/G1, while 5573% of the M12 SOD-2 cells from sense clones 1 and 2 resided in G0/G1. These data indicate a delay at G0/G1 of the cell cycle. Further, 7.171% of the DNA from the M12 SOD-2 sense cells was in the sub-G0 area consistent with apoptotic or necrotic cells compared to 3.070.5% of the M12 control cells. These data are consistent with the increased apoptosis in M12 SOD-2 sense cells determined by caspase 3/7 cleavage.
Results of GSH/GSSG assays
To assess intracellular redox state, cellular GSH and GSSG were measured by spectrophotometry in both 21 and 4% concentrations of O 2 . In this study, 4% O 2 was included because it is the physiological concentration in vivo and represents the concentration in the nude mice study. As shown in Figure 5 , levels of GSH in all of the MnSOD transfectants, except for the M12 SOD-2 Sense 1, were slightly decreased when cells were grown in 21% O 2 . There was a slight decrease in GSH in the control cells grown in 4% O 2 compared with that in 21% O 2 . However, levels of GSH were dramatically decreased in all of the transfectants when grown in 4% O 2 . Levels of GSSG were decreased in all of the transfectants grown in 21% O 2 . In contrast, levels of GSSG were increased in all of the transfectants, except for the AS 2, grown in 4% O2; the changes were more dramatic in the sense transfectants. The ratio of GSH to GSSG (GSH : GSSG) was slightly increased in the sense transfectants and dramatically increased in the antisense transfectants in 21% O 2 . In contrast, GSH:GSSG in 4% O 2 was dramatically decreased in all of the transfectants, except for AS 1 which showed an increase in GSH:GSSG in 4% O 2 .
Effect of mac25/IGFBP-rP1, SOD-2, and H 2 O 2 on signal transduction SOD-2 through the generation of H 2 O 2 has been demonstrated to alter cell signaling through the phosphorylation of MAP kinase, and the increase in MAP kinase activation has been suggested to play a role in tumor growth (Wartenberg et al., 1999) . Therefore, we examined MAP kinase activation to determine if this pathway could, in part, be a mechanism for the activity seen with expression of mac25. M12 mac25/IGFBP-rP1-and SOD-2-expressing cells demonstrated an increase in basal levels of phosphorylated MAP kinase compared to M12 control cells (Figure 6a ). Since H 2 O 2 has been demonstrated to function as an intracellular signaling molecule, we also examined M12 control cells following addition of H 2 O 2 and saw a marked increase in phosphorylation of MAP kinase (Figure 6b ). No further increase in MAP kinase phosphorylation was noted in M12 SOD-2 or mac25/IGFBP-rP1 cells with the addition of H 2 O 2 . Inhibition of MAP kinase with PD 098059, an inhibitor of extracellular receptor kinase 1 and 2, resulted in a small but significant decrease in cell proliferation as determined by the MTT assay ( Figure 7 ). PKB/Akt phosphorylation was also increased in the M12 mac25/IGFBP-rP1 cells and inhibition of PI-3 kinase by LY294002 resulted in a dramatic decline in cell viability when compared to control cells. A similar increase in Akt activity was observed following H 2 O 2 administration (data not shown).
SOD-2 expression in M12 cells induces a senescent phenotype
When SOD-2 was expressed in M12 cells they increased SA-b galactosidase staining consistent with a more senescent phenotype (Table 2) . We have previously demonstrated that mac25/IGFBP-rP1 expression in M12 cells is associated with an increase in a senescent phentoype (Sprenger et al., 2002) .
SOD-2 promoter stimulation in mac25/IGFBP-rP1-expressing cells
In order to determine if the increase seen in SOD-2 occurred through an increase in SOD-2 transcription, we transiently transfected a SOD-2 promoter construct in a PGL3-luc reporter plasmid into either M12 control or M12 mac25/IGFBP-rP1-expressing cells. As noted in Figure 8 , there was a significant increase in promoter activity in the M12 mac25/IGFBP-rP1-expressing cells when compared to M12 control cells.
Discussion
Recent publications have suggested that mac25/IGFBPrP1 is transported to the cell nucleus and has a nuclear localization sequence, it may either be a transcription factor or cofactor (Wilson et al., 2001) . In this study, we used a cDNA microarray representing 6000 genes expressed in the prostate to determine if the mac25/ IGFBP-rP1 induced expression of genes that are capable of inducing the senescent phenotype. Of the eight genes that were upregulated by mac25/IGFBP-rP1, SOD-2 appeared the most likely candidate. SOD-2 is located in mitochondria and belongs to a family of superoxide dismutase enzymes that converts superoxide radicals to H 2 O 2 , which is subsequently converted by catalase or glutathione peroxidase to H 2 O and O 2 (McCord, 2000; Oberley, 2001) . In addition to functioning as an antioxidant, SOD-2-also participates in cell signaling pathways by H 2 O 2 production (Rhee et al., 2000) . It should be noted that SOD-2-transfected cells can adapt to the transfection and not increase their production of H 2 O 2 by decreasing SOD-1 or increasing catalase or GPX (Li et al., 1998b) . This adaptation did not appear to occur in our cells since Western analysis of SOD-1 and catalase was unchanged. H 2 O 2 has been shown to induce features of the senescent cell phenotype including G1 cell cycle arrest, decreased phosphorylation of retinoblastoma protein (pRb), expression of SA b-galactosidase, and cell enlargement. In a previous publication, we have shown that all of these features except cell enlargement occur in M12 cells expressing mac25/ IGFBP-rP1 (Sprenger et al., 2002) . In the present study, we sought out which of these features could be explained by mac25/IGFBP-rP1-induced expression of SOD-2, and further, if SOD-2 expression could account for tumor suppression. In the M12 cells in which SOD-2 was expressed, we found an increase in SA-b galactosidase staining, increased MAP kinase and Akt activity with increased dependence on Akt for survival, an increase in p16 ink expression, decreased growth rate, and an increase in apoptosis. The increase in SA-b galactosidase was not seen in the antisense SOD-2 cells, further indicating the induction of senescence by SOD-2. Tumor growth in nude mice was markedly suppressed by SOD-2 expression but not to the degree seen with mac25/ IGFBP-rP1. This suggests that other functions regulated or influenced by mac25/IGFBP-rP1 also contributed to the inhibition of tumor growth. However, it is important to note that the anitsense SOD-2 construct, which inhibited SOD-2 expression, caused a marked increase in the rate of tumor growth. The suppression of growth by SOD-2 expression and stimulation of growth when SOD-2 expression is decreased suggest that SOD-2 is an important regulator of prostate tumor growth. In the PC-3 cells, although SOD-2 is expressed, there were no changes in the level of expression when mac25/IGFBPrP1 was expressed and no change in tumor growth was noted.
Immunohistochemistry has demonstrated that SOD-2 is decreased in prostate intraepithelial neoplasia and prostate cancer in men. A recent study describing a SOD-2 polymorphism at Val 16 suggested a twofold increased risk for prostate cancer in men with this polymorphism (Sachdeva et al., 2001 ). Overexpression of SOD-2 in the human prostate cancer cell line DU-145 has also been shown to produce effects similar to those we have described in the M12 cells with slower cell growth because of a delay in G1 of the cell cycle, Superoxide dismutase-2 and tumor suppression by Mac25 SR Plymate et al decreased cell viability, and decreased tumor volume in nude mice (Li et al., 1998b) . The additional importance of SOD-2 expression on suppression of prostate cancer growth was recently shown by its induction following selenium administration in vitro to LNCaP cells (Zhong and Oberley, 2001) . In that study, the increase in SOD-2 following selenium administration was associated with a decrease in apoptosis and a delay at the G2/M cell-cycle checkpoint. The increase in basal activation of MAP kinase by cells responding to mac25/IGFBP-rP1, SOD-2, or H 2 O 2 suggests a pathway by which the generation of H 2 O 2 could decrease cell growth. Although acute stimulation of MAP kinase is associated with cell proliferation, chronic elevation of phosphorylated MAP kinase has been associated with decreased cell growth, differentiation, and apoptosis (Birkenkamp et al., 1999; Bost et al., 2002) . The mechanisms for these effects are not entirely clear, but have been suggested to involve inhibition of cyclin D and stimulation of p38 MAP kinase. In our studies, the marked increase in phosphorylated MAP kinase was associated with a slight decrease in proliferation when inhibited with PD 095049, but the decrease in cell viability was not nearly as great as that seen with inhibition of PI3 kinase. This suggests that the dependence on PI3 kinase is a response to induction of other cell death pathways by SOD-2 expression. The mechanisms by which SOD-2 can lead to increased cell death have recently been reviewed (Kim et al., 2001; Oberley, 2001; Sprenger et al., 2002) . Our previous data suggest that the apoptosis may be associated with the unscheduled expression of cyclin A (Sprenger et al., 2002) . Although studies from many laboratories have demonstrated that SOD-2 inhibits tumor growth through interruption of the cell cycle, the effects on apoptosis have not been as straightforward since some studies have shown protection from apoptosis, while others have demonstrated increased apoptotic cell death (Kim et al., 2001) . One potential mechanism for induction of apoptosis in this study could be through the reduced GSH/GSSH ratio in the SOD-2 sense cells. As GSH is consumed and GSSG is produced in excess of GSH, there is a relative change in the redox state of the cell to one of greater oxidation. As the cells are exposed to increased oxidative stress, viability is lost and cell death may occur (Zhong and Oberley, 2001 ). This change in the redox environment of the mitochondria inhibits pyruvate carboxylase and enhances the toxicity of *NO (Kim et al., 2001) . Another mechanism for SOD-2-induced apoptosis is through its ability to activate p53 by the production of H 2 O 2 (Huang et al., 2000; Kinscherf et al., 1998) . We have demonstrated that expression of mac25/IGFBP-rP1 is associated with activation of p53; therefore, this mechanism of induction of apoptosis by SOD-2 through p53 is relevant to the current model (Sprenger et al., 2002) . Additionally, proapoptotic activity may result by signaling via the ras pathway with activation of raf1 as suggested by the increase in MAP kinase phosphorylation. (Widmann et al., 1998) .
In summary, this study used transcript profiling methods to identify genes regulated by the expression of mac25/IGFBP-rP1 that are responsible for tumor suppression. It further demonstrates the significance of SOD-2 as a potential regulatory protein in prostate cancer development.
Materials and methods
Materials
Tissue culture media, RPMI-1640, gentamicin, fungizone, geneticin (G418), and deoxyribonuclease were obtained from Life Technologies (Gibco-BRL) (Grand Island, NY, USA). Epidermal growth factor (EGF), dexamethasone, and the additive ITS (insulin, transferrin, selenium) were purchased from Sigma Chemical Co. (St Louis, MO, USA). Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). Tfxt-50 Reagent was obtained from Promega (Madison, WI, USA). The BCA protein assay kit was from Pierce Biological (Rockford, IL, USA). The IGFBP-rP1 cDNAs were obtained as previously described from a cDNA library made from the human breast carcinoma cell line, Hs578T (Oh et al., 1996) . Mac25/IGFBP-rP1 polyclonal anti-rabbit antibody was provided as a generous gift by Drs V Hwa and R Rosenfeld at Oregon Health Sciences University, Portland OR. Characterization of this antibody in our laboratory has been previously described (Hwa et al., 1998b) . SOD-2 antibody was purchased from Upstate Biological (Lake Placid, NY, USA) and actin antibody was from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Horseradish peroxidase-linked donkey anti-rabbit IgG and enhanced chemiluminescence (ECL) detection reagents were purchased from Amersham (Arlington Heights, IL, USA). Each experiment was performed at least three separate times. SOD-2 human cDNA was I.M.A.G.E. Consortium clone 124182 was from ATCC (Manassas, VA, USA). The cDNA was cut with EcoR1(5 0 ) and HindIII (3 0 ) restriction enzymes and subsequently ligated into pcDNA 3.1+ and Àhygromycin-resistant mammalian expression plasmids (Invitrogen, Carlsbad, CA, USA) to obtain plasmids expressing sense or antisense cDNAs. Antibodies for Akt, phospho-Akt, Erk, and phospho-Erk were obtained from Biosource International (Camarillo, CA, USA). All commercial antibodies were used in the dilutions indicated by the manufacturer.
Cell culture
The derivation of the M12 cell line has been previously described (Bae et al., 1994 (Bae et al., , 1995 (Bae et al., , 1998 Jackson-Cook et al., 1996) . Briefly, human prostate epithelial cells were immortalized with SV40-T antigen to produce the poorly tumorigenic P69SV40 T (P69) cell line. P69 cells were injected subcutaneously into athymic nude mice, producing tumor nodules in 2/18 animals after 180 days. These nodules were reimplanted in athymic mice and after three passages resulted in the M12 cells, which demonstrated a short latency period of 7-10 days to tumor formation in 10/10 animals and were locally invasive and metastatic. Cells were cultured in RPMI-1640 medium supplemented with 10 ng/ml EGF, 0.02 mm dexamethasone, 5 mg/ml insulin, 5 mg/ml transferrin, 5 ng/ml selenium, fungizone, and gentamicin at 371C under 5% CO 2 . PC-3 and LNCaP cells were obtained from ATCC (Bethesda, MD, USA) and grown in the same medium as the M12 cells with the addition of 5% FBS. All cells used in these experiments were mycoplasma free, as determined by the Mycoplasma PCR Primer Set (Stratagene, La Jolla, CA, USA). Additional cell cultures were performed under reduced O 2 at 1 and 4% concentrations.
Transfection
The construction of the M12 cells with stable expression of mac25/IGFBP-rP1 has been previously described (Sprenger et al., 1999) . PC-3 and LNCaP mac25/IGFBP-rP1-expressing cells were constructed using the same mac25/IGFBP-rP1 pcDNA3 plasmid constructs used to make the M12 mac25/ IGFBP-rP1 cell lines (Sprenger et al., 1999) . Transfection was done using Tfx20 (Promega, Madison, WI, USA). SOD-2 cDNA transfections were using Lipofectamine (GIBCO/LifeTechnologies, Rockville, MD, USA) performed as previously described (Sprenger et al., 1999) . Several clones from each transfection that were resistant to the selective antibiotic, G418, were selected and evaluated by Western and Northern blotting to assure appropriate gene expression or suppression. At least two clones from each transfection were used in subsequent experiments.
Western immunoblots
Media or cell lysates were collected as previously described (Sprenger et al., 1999) . After concentration of 1 ml medium onto nitocellulose (Bio-Rad, Hercules, CA, USA) using a dotblot apparatus, the proteins were redissolved in 50 ml SDS sample buffer (0.5 m Tris, pH 6.8, 1% SDS, 10% glycerol, 0.003% bromophenol blue, and 8 m urea) by heating for 10 min at 1001C as previously described (Birnbaum et al., 1994) . Samples were electrophoresed on 12% SDS-polyacrylamide gels (PAGE), then electroblotted onto nitrocellulose (Bio-Rad, Hercules, CA, USA). Western blots were incubated in 0.3% Tween-20 in TBS overnight at 41C. Mac25/IGFBPrP1 antibody dilution was 1 : 3000, all other antibodies were diluted 1 : 1000. Bound antibody was detected using a horseradish peroxidase-linked donkey anti-rabbit secondary antibody and the ECL detection system according to the manufacturer's protocol. Buffers and wash times were as suggested by the manufacturer, except that the nitrocellulose was first washed with 10% H 2 O 2 for 10 min. A measure of 40 mg of protein was loaded per lane unless otherwise specified.
RNA analysis
Cells were grown to approximately 80% confluence, at which time total RNA was isolated using an acid guanidinium thiocyanate/phenol/chloroform extraction method as previously described (Plymate et al., 1996) . Approximately 10 mg of each RNA preparation (quantitated by optical density at 260 nm) was separated by electrophoresis on a 1% agarose/6% (2.2 m) formaldehyde gel, transferred overnight by capillary action onto a nylon membrane (GeneScreen, DuPont, Wilmington, DE, USA), and crosslinked to the membrane by UV irradiation in a Stratalinker 1800 (Stratagene, LaJolla, CA, USA). Northern blot analysis was performed by hybridizing the membrane overnight with the mac25/IGFBPrP1 or SOD-2 cDNA probe labeled with [ 32 P]dCTP to a specific activity of 10 8 d.p.m./mg DNA by the random primers method. Hybridization was carried out at 421C in a solution of 5 Â Denhardt's solution with 50 mg/ml sonicated salmon sperm DNA and 50% deionized formamide. Following a final wash with 0.1 Â SSC at 651C, the blot was exposed to X-ray film (Kodak X-Omat-AR) with an intensifying screen at À801C for 48-72 h.
Tumor formation in vivo
Groups of 10 nude, athymic male mice were injected subcutaneously with 10 6 cells from the respective cell lines. All cell lines were injected in PBS except for the LNCaP cell line, which was injected with a 1 : 1 ratio of Matrigelt and PBS. Mice were then monitored biweekly for tumor formation and weight gain/loss for 8 weeks. If tumors were present, tumor volume was calculated using the formula: (l Â w 2 )/2 (where l ¼ length and w ¼ width of tumor). Statistical analyses using Kruskal-Wallis (for comparing the rate of tumor formation) and the Mann-Whitney U-test (for comparing tumor volumes) were then performed. After 8 weeks, the mice were killed and their tumors removed. These tumors were then digested with 0.1% collagenase (Type I) and 50 mg/ml DNAse (Worthington Biochemical Corp., Freehold, NJ, USA). Dispersed cells were plated in ITS medium/5% FBS at 5% CO 2 , with 200 mg/ml G418, at 371C for 24 h to allow attachment. When the cells had reached 80% confluence, they were split at a 1 : 4 ratio into 60 mm dishes. After the cells had reached 80% confluence, they were switched to serum-free medium and 24 h later media were collected and the cells in the dishes from which the media had been collected were counted. RNA was collected from separate plates using the RNeasytkit (Qiagen, Valencia, CA, USA). Media and RNA were collected and Western immunoblots and Northern blots were run to confirm that the tumor cells retained the mac25/IGFBP-rP1 phenotype of the injected cells.
Microarray fabrication
A nonredundant set of 6000 prostate-derived cDNA clones was identified from the Prostate Expression DataBase (PEDB), a public sequence repository of expressed sequence tag (EST) data derived from human prostate cDNA libraries (Hawkins et al., 1999) . Preparation of PCR products onto glass slides has been previously described (Pritchard et al., 2001) .
Probe construction and microarray hybridization
Total RNA was isolated from each of the cell lines using TRIzol (Life Technologies). Fluorescence-labeled probes were made from 30 mg total RNA in a reaction volume of 20 ml containing 1 ml anchored oligo-dT primer (Amersham), 0.05 mm Cy3-dCTP (Amersham), 0.05 mm dCTP, 0.1 mm each dGTP, dATP, dTTP, and 200 U Superscript II reverse transcriptase (Life Technologies). Reactants were incubated at 421C for 120 min followed by heating to 941C for 3 min. Unlabeled RNA was hydrolyzed by the addition of 1 ml of 5N NaOH and heating to 371C for 10 min. A volume of 1 ml of 5 m HCl and 5 ml of 1 m Tris-HCl (pH 7.5) were added to neutralize the base. Unincorporated nucleotides and salts were removed by chromatography (Qiagen), and the cDNA was eluted in 30 ml dH2O. A measure of 1 mg of dA/dT 12-18 (Pharmacia) and 1 mg of human Cot1 DNA (Life Technologies) were added to the probe, heat denatured at 941C for 5 min, combined with an equal volume of 2X microarray hybridization solution (Amersham) and prehybridized at 501C for 1 h. The mixture was then placed onto a microarray slide with a coverslip and hybridized in a humid chamber at 521C for 16 h. The slides were washed once with 1 Â SSC, 0.2% SDS at room temperature for 5 min, then twice with 0.1 Â SSC and 0.2% SDS at room temperature for 10 min.
Image acquisition and data analyses
Fluorescence intensities of the immobilized targets were measured using a laser confocal microscope (Molecular Dynamics). Intensity data were integrated at a pixel resolution of 10 mm using approximately 20 pixels per spot, and recorded at 16 bits. Quantitative data were obtained with the SpotFinder V 2.4 program written at the University of Washington. Local background hybridization signals were subtracted prior to comparing spot intensities and determining expression ratios. For each experiment, each cDNA was represented twice on each slide, and the experiments were performed in duplicate producing four data points per cDNA clone per hybridization probe. Intensity ratios for each cDNA clone hybridized with probes derived from the respective cell line were calculated (mac25/IGFBP-rP1 intensity/control intensity). Gene-expression levels were considered significantly different between the two conditions if all four replicate spots for a given cDNA demonstrated a ratio >2 or o0.5, and the signal intensity was greater than 2 s.d above the image background. We have previously determined that expression ratios less than 1.5 are not reproducible in our system (data not shown).
Promoter assay
The human SOD-2 promoter plasmid construct was a generous gift from Dr Moon Bin Yin (Bethesda, MD, USA) and consisted of a 3.6 kb pair from the SOD-2 gene containing the 5 0 flanking region to the transcription site, exon 1 and part of intron 1 (from À3340 to +260 nucleotide residues) ligated into the pGL3-basic vector (Kim et al., 1999) .
For the transient transfections, cells were plated in a 96-well plate at 1 Â 10 4 cells per well. At 80% confluence, the cells were transfected with the SOD-2 promoter/luciferase vectors using Tfx-20 according to the manufacturer's protocol (Promega). Briefly, each well received 0.1 mg vector DNA using a 3 : 1 charge ratio of Tfx-20/DNA to vector DNA in 40 ml RPMI as determined by the manufacturer (Promega Co., Madison, WI, USA). After 1 h, 100 ml of 1% serum-containing media was added and the cells were incubated for 24 h. Luciferase activity was then measured.
Luciferase activity was determined using the Luciferase Assay System (Promega). Cells were lysed with 20 ml 1 Â reporter lysis buffer and luciferase activity was measured using a Wallac Inc. Victor 2 microplate reader (Perkin Elmer, Gaithersburg, MD, USA) with 100 ml of luciferase assay buffer injected automatically and read for 10 s. Transfection efficiency was determined by transfection of triplicate wells with the pGL3 control vector in which luciferase expression is driven by the simian virus 40 promoter. The coefficient of variation of transfection was determined from five experiments of triplicate wells and was 1.9% CV with a transfection efficiency of 8076% between experiments. Separate triplicate cells were transfected with a pGL3 basic luciferase reporter vector, lacking the SOD-2 insert and another promoter, which served as a nonspecific control.
SOD enzymatic activity
Total SOD activity was determined using 1x10 7 -2x10 7 control or experimental cells that were rinsed with PBS, trypsinized and pelleted by centrifugation. Pellets were reconstituted in 100 ml of water. Cells were then disrupted by three freeze-thaw cycles at À701C. After the final thaw, pellets were spun at 3000 g at 41C. A 1 : 10 dilution of the cell homogenate was then used for the assay. The SOD activity was measured using a kit from Calbiochem (SanDiego, CA, USA). This assay measures the rate of oxidation of 5,6,6a,1 1b-tetrahydro-3,9,10-trihydroxylbenzo(c)fluorene. The oxidation of this compound yields a chromophore that absorbs at 525 nm. The concentration of SOD activity is measured in SOD-525 units determined from the ratio of the velocity sample : velocity control compared to a ratio provided by the manufacturer.
Specific SOD-2 activity was determined by the method previously described by Sprenger et al. (2002) .
Flow cytometry using propidium iodide
Flow cytometry was performed as previously described (Sprenger et al., 2002) . Briefly, cells were grown to 80% confluence. Cells (2 Â 10 6 ) were pelleted and washed with PBS. Pellets were resuspended in cold 70% ethanol to a final density of 1 Â 10 6 cells/ml, then pelleted and resuspended in 1 ml of DNA staining solution (PBS, pH 7.4, containing 0.1% Triton X-100, 0.1 mm EDTA (pH 7.4), 0.05 mg/ml RNase A (50 U/ mg), and 50 mg/ml propidium iodide). Cells were read on a Becton-Dickinson FACS Caliber at a wavelength of 488 nm. Data were collected and analysed using CellQuest and ModFit software, respectively.
GSH assay
Cell pellets were suspended in phosphate buffer (PB: 50 mm potassium phosphate buffer, pH 7.8), and a small aliquot was used for protein quantitation. For glutathione assay, protein precipitation was carried out by mixing one volume of cell suspension with one volume of 10% 5-sulfosalicylic acid and centrifuged at 15 000 r.p.m. for 5 min at 41C. The supernatants were collected and total glutathione was measured in a DU640 spectrophotometer (Beckman) as previously described (Li et al., 1998a) . Oxidized glutathione was indirectly estimated by measuring reduced glutathione after the supernatants were incubated in 2-vinylpyridine for 90 min at 41C.
Cell growth assay
The growth rate of each cell type and clone was determined by counting the number of cells as a function of time. Cells were incubated at 371C, 5% CO 2 . Before counting, medium was aspirated, 3 ml of 1 Â PBS was added and aspirated, and 2 ml of 1 Â trypsin was added to each well. Cells were incubated for 10 min at 371C, 5% CO 2 . A volume of 3 ml appropriate medium was added to each well and cells were triturated. Cells were then spun for 3 min at 10 000 r.p.m. followed by reconstitution in a 10 ml medium. Cells were seeded into sixwell plates at 2.5 Â 10 5 cells/well containing 2 ml of appropriate culture medium. Three parallel wells for each of the control and experimental cells, clones A and B, were seeded for each time point. Cells were counted at 24, 48, 72, and 96 h using a hemocytometer. Cells at 1 and 4% O 2 were counted in a similar manner.
Apoptosis
Caspase 3/7 (DEVDase) activity for each cell type and clone was measured using the Apo-ONE homogenous Caspase-3/7 Assay (Promega, Madison, WI, USA) according to the manufacturer's directions, at two time points. Cells were seeded in black-bottomed 96-well plates at 2.5 Â 10 3 cells/well containing 100 ml of culture medium (RPMI, transferrin and selenium). A total of 16 parallel wells for each cell type and clone were seeded for each time point. Cells were incubated at 371C, 5% CO 2 . At 48 and 96 h, 100 ml of Caspase 3/7 Reagent was added to each well of separate plates. These plates were covered with foil, placed on shaker, and read 2.5 h later on a Wallac Victor 2 1420 fluorescent plate reader at an excitation wavelength of 485 nm and an emission wavelength of 530 nm. Apoptosis was also assessed by PARP cleavage. In this assay cells were grown in 60 mm dishes. At 24 h after plating in complete medium, cells were changed to RPMI-1640+trans-ferrin and selenium. Both floating and adhered cells were collected from separate plates at 48 and 96 h after complete medium was removed. Cell lysates were collected and run on a 7.5% SDS PAGE. Western immunoblots were performed with an anti-polyadenosylribose polymerase (PARP) antibody that recognizes the 85 kDa cleaved fragment (Promega Co., Madison, WI, USA).
